Evaluation of reward processes in an animal model of depression

被引:106
作者
Slattery, David A.
Markou, Athina
Cryan, John F. [1 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Dept Pharmacol & Therapeut, Cork, Ireland
[2] Novartis Pharma AG, Novartis Pharma Inst BioMed Res, Neurosci Res, Basel, Switzerland
[3] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA
关键词
animal model; reward; depression; antidepressant;
D O I
10.1007/s00213-006-0630-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale Anhedonia is a core symptom of major depression. Deficits in reward function, which underlie anhedonia, can be readily assessed in animals. Therefore, anhedonia may serve as an endophenotype for understanding the neural circuitry and molecular pathways underlying depression. Objective Surprisingly, there is scant knowledge regarding alterations in brain reward function after olfactory bulbectomy (OB), an animal model which results in a behavioural syndrome responsive to chronic antidepressant treatment. Therefore, the present studies aimed to assess reward function after bulbectomy. Materials and methods The present study utilized sucrose preference, cocaine-induced hyperlocomotion and intra-cranial self-stimulation (ICSS) responding to examine reward processes in the OB model. Results Bulbectomized animals showed a marked preference (> 90%) for 0.8% sucrose solution compared with water; similar to the preference exhibited by sham controls. Importantly, there were pronounced deficits in brain reward function, as assessed using ICSS, which lasted 8 days before returning to baseline levels. Furthermore, bulbectomized animals were hyper-responsive to the locomotor stimulating properties of an acute and a repeated cocaine regimen. However, no difference in ICSS facilitation was observed in response to an acute cocaine injection. Conclusions Taken together, these results suggest that bulbectomized rats display alterations in brain reward function, but these changes are not long-lasting and thus, not amenable to investigating the effects of pharmacological interventions. However, given that OB animals are hypersensitive to drugs of abuse, bulbectomy may be an appropriate inducing factor for the development of animal models of co-morbid depression and drug dependence.
引用
收藏
页码:555 / 568
页数:14
相关论文
共 63 条
[21]   Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study [J].
Hasegawa, S ;
Watanabe, A ;
Nguyen, KQ ;
Debonnel, G ;
Diksic, M .
PSYCHOPHARMACOLOGY, 2005, 179 (04) :781-790
[22]   Discovering endophenotypes for major depression [J].
Hasler, G ;
Drevets, WC ;
Manji, HK ;
Charney, DS .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (10) :1765-1781
[23]   Intravenous self-administration of amphetamine is increased in a rat model of depression [J].
Holmes, PV ;
Masini, CV ;
Primeaux, SD ;
Garrett, JL ;
Zellner, A ;
Stogner, KS ;
Duncan, AA ;
Crystal, JD .
SYNAPSE, 2002, 46 (01) :4-10
[24]   Impaired fear memory and decreased hippocampal neurogenesis following olfactory bulbectomy in rats [J].
Jaako-Movits, K ;
Zharkovsky, A .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (11) :2871-2878
[25]   DOPAMINE TRANSMISSION IN THE INITIATION AND EXPRESSION OF DRUG-INDUCED AND STRESS-INDUCED SENSITIZATION OF MOTOR-ACTIVITY [J].
KALIVAS, PW ;
STEWART, J .
BRAIN RESEARCH REVIEWS, 1991, 16 (03) :223-244
[26]  
Keilhoff Gerburg, 2006, Neuropsychopharmacology, V31, P1165
[27]  
KELLY JP, 1993, NEUROPSYCHOPHARMACOL, V9, pS137
[28]   The olfactory bulbectomized rat as a model of depression: An update [J].
Kelly, JP ;
Wrynn, AS ;
Leonard, BE .
PHARMACOLOGY & THERAPEUTICS, 1997, 74 (03) :299-316
[29]   Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication [J].
Kessler, RC ;
Berglund, P ;
Demler, O ;
Jin, R ;
Walters, EE .
ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (06) :593-602
[30]  
KORNETSKY C, 1979, FED PROC, V38, P2473